Current status and prospects of immunotherapy in esophageal cancer
10.3760/cma.j.issn.1673-422X.2018.08.012
- VernacularTitle:食管癌免疫治疗的现状与展望
- Author:
Xiaoqing YU
1
;
Yun FAN
Author Information
1. 浙江省肿瘤医院胸部肿瘤内科
- Keywords:
Esophageal neoplasms;
Immunotherapy
- From:
Journal of International Oncology
2018;45(8):502-505
- CountryChina
- Language:Chinese
-
Abstract:
The treatment of esophageal cancer is difficult in clinic.Recently,the development of immune checkpoint inhibitors has brought the immunotherapies to a new age.In predicting the curative effect of biomarkers,programmed cell death-ligand 1,tumor mutation burden and microsatellite instability could promisingly predict the effect of the immune checkpoint inhibitors.Various immune checkpoint inhibitors are emerging and the combination of immunotherapy have shown a great applied potential in a series of clinical trials of esophageal cancer.
